Toniatti C, Bujard H, Cortese R, Ciliberto G
1I.R.B.M.-P. Angeletti, Via Pontina Km. 30.600, 00040 Pomezia, Rome, Italy.
Gene Ther. 2004 Apr;11(8):649-57. doi: 10.1038/sj.gt.3302251.
The clinical efficacy and safety as well as the application range of gene therapy will be broadened by developing systems capable of finely modulating the expression of therapeutic genes. Transgene regulation will be crucial for maintaining appropriate levels of a gene product within the therapeutic range, thus preventing toxicity. Moreover, the possibility to modulate, stop or resume transgene expression in response to disease evolution would facilitate the combination of gene therapy with more conventional therapeutic modalities. The development of ligand-dependent transcription regulatory systems is thus of great importance. Here, we summarize the most recent progress in the field.
通过开发能够精确调节治疗性基因表达的系统,基因治疗的临床疗效、安全性以及应用范围将得到拓展。转基因调控对于在治疗范围内维持基因产物的适当水平从而防止毒性至关重要。此外,根据疾病进展调节、停止或恢复转基因表达的可能性将有助于基因治疗与更传统治疗方式的联合应用。因此,配体依赖性转录调控系统的开发具有重要意义。在此,我们总结该领域的最新进展。